Diadem
Blood-based test for the early prediction of Alzheimer‘s disease.
Diadem has raised €10M across 1 funding round from 2 investors, most recently a round in Mar 2022. Based in Brescia, Italy; active in Healthtech. Data as of 28 Oct 2026.
Brescia, Italywww.diademdx.com ↗
Total raised
€10M
€10,000,000
Funding rounds
1
Investors
2
distinct backers
Active since
2022-03
latest 2022-03
Funding by year
EUR raised per yearDiadem — funding by year — interactive chart.
Data table
| Diadem — funding by year | |
|---|---|
| 2022 | €10M |
Signals
High confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-03-29 | Other | €10M | CDP Venture Capital,Panakès Partners | View deal → |
Investors
2Related news
- Italian startup Diadem raises €10M to develop a platform for early Alzheimer’s detectionsiliconcanals.com · 2022-03
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Bending Spoons€1.7BItaly · Software
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
Global coverage: FundingData